We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Photoswitchable Flow Cytometry Directly Tracks Single Circulating Tumor Cells

By LabMedica International staff writers
Posted on 22 May 2014
A original method has been developed that allows investigators to label and track single tumor cells circulating in the blood and this advance could help to develop a better understanding of cancer spread and how to stop it.

The innovative method allows for labeling and tracking of individual circulating cancer cells throughout the body, thereby helping scientists to elucidate the pathways of single cells from start to finish, including invasion into nearby normal tissue, movement into the lymphatic system or the bloodstream. More...


An international team led by those at the University of Arkansas for Medical Sciences (Little Rock, AR, USA) used photoswitchable fluorescent proteins that change their color in response to light. When the first laser of light hits the circulating tumor cells, they appear to be fluorescent green. A second laser, using a different wavelength, makes the cells appear to be fluorescent red. To label individual cells, the scientists used a very thin violet laser beam aimed at small blood vessels. The fluorescence from each cell is collected, detected, and reproduced on a computer monitor as real-time signal traces, allowing the investigators to count and track individual cells in the bloodstream.

In tumor-bearing mice, the scientists could monitor the real-time dynamics of circulating cancer cells released from a primary tumor. They could also image the various final destinations of individual circulating cells and observe how these cells circulate and colonize healthy tissue, existing sites of metastasis, or the site of the primary tumor. The Multicolor Photoswitchable Flow Cytometry (PFC) Platform was based on an Olympus IX81 inverted microscope (Olympus America; Center Valley, PA, USA) with incorporated three continuous-wave lasers.

Ekaterina Galanzha, MD, PhD, the senior author of the study said, “This technology allows for the labeling of just one circulating pathological cell among billions of other normal blood cells by ultrafast changing color of photosensitive proteins inside the cell in response to laser light. Therefore, the approach may give oncologists knowledge on how to intervene and stop circulating cancer cell dissemination that might prevent the development of metastasis.” The study was published on May 8, 2014, in the journal Chemistry & Biology.

Related Links:

University of Arkansas for Medical Sciences
Olympus America  



New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
HPV Molecular Test
BD Onclarity HPV Assay
New
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.